Gilead Sciences, Inc. financial data

Symbol
GILD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
333 Lakeside Dr, Foster City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 124 % +2.87%
Quick Ratio 15.6 % +16.4%
Return On Equity 5.23 % -79.9%
Return On Assets 1.8 % -79.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.24B shares -0.08%
Common Stock, Shares, Outstanding 1.25B shares -0.08%
Entity Public Float 67B USD +19.9%
Common Stock, Value, Issued 1M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.25B shares -0.16%
Weighted Average Number of Shares Outstanding, Diluted 1.25B shares -0.56%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 27.8B USD +1.55%
Costs and Expenses 25.2B USD +33.5%
Operating Income (Loss) 2.56B USD -69.8%
Nonoperating Income (Expense) -44M USD +78.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.54B USD -79.1%
Income Tax Expense (Benefit) 505M USD -73.5%
Net Income (Loss) Attributable to Parent 1.05B USD -80.8%
Earnings Per Share, Basic 0.84 USD/shares -80.8%
Earnings Per Share, Diluted 0.82 USD/shares -81.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.41B USD +1.39%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 4.66B USD +10.3%
Inventory, Net 2.03B USD +24.1%
Assets, Current 12.3B USD -13.8%
Property, Plant and Equipment, Net 5.35B USD -3.5%
Operating Lease, Right-of-Use Asset 581M USD +15.1%
Intangible Assets, Net (Excluding Goodwill) 22.8B USD -17.7%
Goodwill 8.31B USD 0%
Other Assets, Noncurrent 4.77B USD -6.71%
Assets 53.6B USD -14%
Accounts Payable, Current 537M USD -13.7%
Employee-related Liabilities, Current 852M USD +11.5%
Accrued Liabilities, Current 3.87B USD +2.22%
Liabilities, Current 10.8B USD -22.8%
Accrued Income Taxes, Noncurrent 738M USD -71.7%
Deferred Income Tax Liabilities, Net 907M USD -56.9%
Operating Lease, Liability, Noncurrent 546M USD +16.9%
Other Liabilities, Noncurrent 1.42B USD +4.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax 93M USD +830%
Retained Earnings (Accumulated Deficit) 11.2B USD -26.2%
Stockholders' Equity Attributable to Parent 18.3B USD -13.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 18.2B USD -13.7%
Liabilities and Equity 53.6B USD -14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.22B USD +27.2%
Net Cash Provided by (Used in) Financing Activities -1.36B USD +3.2%
Net Cash Provided by (Used in) Investing Activities -2.21B USD -167%
Common Stock, Shares Authorized 5.6B shares 0%
Common Stock, Shares, Issued 1.25B shares -0.08%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.37B USD -187%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.77B USD -51.4%
Deferred Tax Assets, Valuation Allowance 663M USD +10.7%
Deferred Tax Assets, Gross 6.21B USD +17.4%
Operating Lease, Liability 671M USD +16.1%
Depreciation 94M USD 0%
Payments to Acquire Property, Plant, and Equipment 105M USD -3.67%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.14B USD -79%
Lessee, Operating Lease, Liability, to be Paid 763M USD +17.2%
Property, Plant and Equipment, Gross 7.77B USD +1.37%
Operating Lease, Liability, Current 125M USD +12.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 123M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 143M USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -723M USD -139%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 92M USD +26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 95M USD +20.3%
Deferred Tax Assets, Operating Loss Carryforwards 417M USD -3.02%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.96B USD +0.15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 76M USD +35.7%
Additional Paid in Capital 7.02B USD +16.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.3B USD +27.8%
Deferred Tax Assets, Net of Valuation Allowance 5.55B USD +18.3%
Interest Expense 968M USD +4.42%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%